1. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000. Issue 6 (22nd May 2007) Authors: Yee, C-S; Isenberg, D A; Prabu, A; Sokoll, K; Teh, L-S; Rahman, A; Bruce, I N; Griffiths, B; Akil, M; McHugh, N; D'Cruz, D; Khamashta, M A; Maddison, P; Zoma, A; Gordon, C Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 6(2008) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Issue 5 (13th April 2004) Authors: Yee, C-S; Gordon, C; Dostal, C; Petera, P; Dadoniene, J; Griffiths, B; Rozman, B; Isenberg, D A; Sturfelt, G; Nived, O; Turney, J H; Venalis, A; Adu, D; Smolen, J S; Emery, P Journal: Annals of the rheumatic diseases Issue: Volume 63:Issue 5(2004) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Issue 1 (17th December 2004) Authors: Yee, C-S; Crabtree, N; Skan, J; Amft, N; Bowman, S; Situnayake, D; Gordon, C Journal: Annals of the rheumatic diseases Issue: Volume 64:Issue 1(2005) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗